Tobacco’s New Leaf ■ 177
Outbreak! Samples of the
flu virus are taken from
sick people and sent to
medical labs to be
sequenced.
Healthy people are
injected with the flu
vaccine and develop
immunity to the flu virus
(see Figure 2.1 for details).
The virus is sequenced,
and the genetic sequence
is sent to Medicago (and
other vaccine producers).
Medicago identifies a
portion of the DNA to
synthesize—in this
case, the gene for
hemagglutinin, a protein
from the virus’s surface.
The hemagglutinin
proteins are purified to
produce a vaccine.
The tobacco is harvested,
and the hemagglutinin
proteins are extracted.
The synthesized hemagglutinin
gene is inserted into the
Agrobacterium genome, and
the bacteria replicate.
The tobacco expresses the
hemagglutinin gene, producing
the hemagglutinin protein that
the gene encodes.
The tobacco is infected
with Agrobacterium,
which transfers the
synthesized
hemagglutinin gene to
the tobacco genome.
1
9
2
8 7
4
6
5
3
Figure 10.5
From outbreak to vaccine
During flu season or any other viral outbreak, a large network of medical professionals and scientists is
activated to create a vaccine quickly and effectively. M
Q1: In which of the step(s) illustrated here does DNA replication occur? In which step(s) does
gene expression occur?
Q2: Why do vaccine producers not simply replicate the entire viral genome, instead isolating the
gene for one protein and replicating only that gene?
Q3: What role do the bacteria play in this process? Why are they needed?
RNA polymerase binds to a segment of DNA
near the beginning of the gene that is called
a promoter. The promoter contains a specific
sequence of DNA bases that the RNA poly-
merase recognizes and binds. At Medicago,
scientists attach specific promoters to the
hemagglutinin gene so that the plant cell’s
RNA polymerase can identify the gene and
actively transcribe it, maximizing the rate of
transcription, says Vézina.